you are viewing a single comment's thread
view the rest of the comments
[–] 36 points 10 hours ago* (last edited 9 hours ago) (2 children)

LOL....experimental in mice, meanwhile, The CIM in Cuba already trialed and approved a nasal delivered drug for Alzheimers and Americans are sneaking over to buy it.

$25 for 10 doses -this is unacceptable for USA, so it needs to be reinvented and sold for $25,000/yr.

For those interested it was the athenea trial and was approved in 2023. Two year follow up shows AD progression is still slowed in 2025.

NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial - PubMed https://share.google/5eaJS93aAPZnIVNBR

  • source
  • hideshow 2 child comments